A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : TTR

Search Conditions:
Search Keyword : TTR
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: TTR
Appearance Frequency: 3495 time(s)
Long forms: 231

Display Settings:
[Display Entries]
Long Form, 100 entries
    (Appearance freq, Descending)
Long Form, all entries
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
transthyretin
(2108 times)
Biochemistry
(455 times)
FAP (340 times)
RBP (133 times)
ATTR (87 times)
1984 Immunocytochemical studies on the localization of plasma and of cellular retinol-binding proteins and of transthyretin (prealbumin) in rat liver and kidney.
therapeutic range
(545 times)
Vascular Diseases
(121 times)
INR (213 times)
AF (145 times)
VKA (66 times)
2006 Worldwide management of oral anticoagulant therapy: the ISAM study.
time to recurrence
(264 times)
Neoplasms
(154 times)
OS (171 times)
HCC (73 times)
HR (44 times)
1993 Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients.
time to relapse
(54 times)
Neoplasms
(24 times)
OS (22 times)
NSCLC (8 times)
AML (5 times)
1989 LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma.
time to response
(48 times)
Neoplasms
(26 times)
ORR (24 times)
DOR (23 times)
PFS (22 times)
1981 Relationship between time to treatment failure and survival and between time to response and response duration in metastatic breast cancer. Implications for treatment.
time-to-result
(22 times)
Microbiology
(11 times)
AST (4 times)
LOD (4 times)
BC (2 times)
2002 Identification and antimicrobial susceptibility testing of clinical isolates of nonfermenting gram-negative bacteria by the Phoenix Automated Microbiology System.
wild-type transthyretin
(22 times)
Biochemistry
(4 times)
SSA (7 times)
FAP (3 times)
HFpEF (2 times)
1996 Structure of the Val122Ile variant transthyretin - a cardiomyopathic mutant.
time to tumor recurrence
(21 times)
Neoplasms
(11 times)
OS (12 times)
HR (7 times)
CI (5 times)
2008 Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer.
time-in-therapeutic range
(16 times)
Vascular Diseases
(11 times)
AF (4 times)
INR (4 times)
HR (3 times)
2004 Quality assessment of anticoagulation dose management: comparative evaluation of measures of time-in-therapeutic range.
10  tracer-to-tracee ratio
(12 times)
Physiology
(4 times)
EGP (2 times)
GC/MS (2 times)
IVGTT (2 times)
1997 Measurement of very low stable isotope enrichments by gas chromatography/mass spectrometry: application to measurement of muscle protein synthesis.
11  transthyretin gene
(12 times)
Neurology
(2 times)
AAO (1 time)
ATTR (1 time)
BCVA (1 time)
2009 Transthyretin gene (TTR) intron 1 elucidates crocodylian phylogenetic relationships.
12  thermotolerance ratio
(11 times)
Neoplasms
(6 times)
CHM (2 times)
PUR (2 times)
SUH (1 time)
1984 Heat sensitivity and thermotolerance in cells from five human melanoma xenografts.
13  time to resolution
(11 times)
Neoplasms
(8 times)
TTO (4 times)
sTRAEs (3 times)
IMM (2 times)
2014 Neighborhood factors associated with time to resolution following an abnormal breast or cervical cancer screening test.
14  type-token ratio
(11 times)
Speech-Language Pathology
(3 times)
MLUw (2 times)
BG (1 time)
BNT (1 time)
1981 Formal thought disorder, the type-token ratio and disturbed voluntary motor movement in schizophrenia.
15  time to recovery
(10 times)
Hematology
(2 times)
HD (2 times)
AUCs (1 time)
BDA (1 time)
1997 The prediction of length of major depressive episodes: results from an epidemiological sample of female twins.
16  target therapeutic range
(8 times)
Vascular Diseases
(3 times)
INR (3 times)
AF (2 times)
CI (1 time)
2003 Acenocoumarol therapy in pediatric patients.
17  tear turnover rate
(8 times)
Ophthalmology
(6 times)
ADDE (2 times)
EDE (2 times)
bTTR (1 time)
2001 An improved fluorophotometric method for tear turnover assessment.
18  anti-transthyretin
(7 times)
Neurology
(4 times)
AAV (1 time)
AD (1 time)
bGH (1 time)
1993 Immunoassay for transthyretin variants associated with amyloid neuropathy.
19  target range
(7 times)
Vascular Diseases
(2 times)
AF (2 times)
INR (2 times)
AC (1 time)
2000 Relationship between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for the design of randomized trials of patient self-management.
20  type transthyretin
(7 times)
Biochemistry
(2 times)
AgRP (1 time)
CAGE (1 time)
DEGs (1 time)
2008 Prefibrillar transthyretin oligomers and cold stored native tetrameric transthyretin are cytotoxic in cell culture.
21  transporter transthyretin
(5 times)
Toxicology
(2 times)
PBDEs (2 times)
AD (1 time)
AR (1 time)
2002 Polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and chlorinated paraffins (CPs) in rats-testing interactions and mechanisms for thyroid hormone effects.
22  transthyretin-related
(5 times)
Transplantation
(1 time)
AL (2 times)
AC (1 time)
ASCT (1 time)
2005 Early onset aggressive hereditary amyloidosis: report of an Italian family with TTR Arg47 mutation.
23  RBP-transthyretin
(4 times)
Biochemistry
(3 times)
RBP (3 times)
Ito (1 time)
mAbs (1 time)
1991 Regulation of retinol uptake and esterification in MCF-7 and HepG2 cells by exogenous fatty acids.
24  Tabtoxin resistance protein
(4 times)
Molecular Biology
(2 times)
AcCoA (2 times)
GNAT (1 time)
HATs (1 time)
2001 Crystallization and preliminary X-ray crystallographic analysis of native and selenomethionyl recombinant tabtoxin-resistance protein complexed with acetyl-coenzyme A.
25  time to disease recurrence
(4 times)
Neoplasms
(4 times)
OS (2 times)
EHC (1 time)
GBC (1 time)
2010 The prognostic value of tumor mitotic rate and other clinicopathologic factors in patients with locoregional recurrences of melanoma.
26  time to readmission
(4 times)
General Surgery
(2 times)
CI (1 time)
ES (1 time)
HF (1 time)
2014 Time-to-readmission and Mortality After High-risk Surgery.
27  time-to-retreatment
(4 times)
Neoplasms
(2 times)
CLL (2 times)
OS (2 times)
PFS (2 times)
2008 Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration.
28  transition temperature range
(4 times)
Orthodontics
(3 times)
DSC (2 times)
Af (1 time)
Ms (1 time)
1980 A clinical trial of alignment of teeth using a 0.019 inch thermal nitinol wire with a transition temperature range between 31 degrees C. and 45 degrees C.
29  translation regulatory
(4 times)
Chemistry
(1 time)
RBPs (3 times)
DSRBPs (1 time)
NF90 (1 time)
2007 Analysis of turnover and translation regulatory RNA-binding protein expression through binding to cognate mRNAs.
30  targeting transthyretin
(3 times)
Therapeutics
(1 time)
1,5-AmNS (1 time)
1,8-ANS (1 time)
siRNA (1 time)
2009 Identification of a novel ligand binding motif in the transthyretin channel.
31  TBG, transthyretin
(3 times)
Neoplasms
(1 time)
TBG (2 times)
ACT (1 time)
AT (1 time)
1992 Effects of interleukin-6 on the expression of thyroid hormone-binding protein genes in cultured human hepatoblastoma-derived (Hep G2) cells.
32  testosterone
(3 times)
Environmental Health
(2 times)
ADD (2 times)
17-HPT (1 time)
17beta-HSD (1 time)
2011 Modulation of estrogen synthesis through activation of protein kinase A in H295R cells by extracts of estuary sediments.
33  tetrameric transthyretin
(3 times)
Molecular Biology
(1 time)
FAP (1 time)
SSA (1 time)
2005 Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors.
34  tetrathionate reductase
(3 times)
Microbiology
(2 times)
TSO (2 times)
TSR (1 time)
1980 Thiosulfate Oxidation and Tetrathionate Reduction by Intact Cells of Marine Pseudomonad Strain 16B.
35  therapeutic International Normalized Ratio range
(3 times)
Vascular Diseases
(1 time)
ACTS (1 time)
AF (1 time)
RE-LY (1 time)
2010 Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA).
36  Thoracic Tumor Registry
(3 times)
Medicine
(1 time)
NSCLC (2 times)
SCLC (2 times)
CT (1 time)
2019 Lung cancer in Spain: information from the Thoracic Tumors Registry (TTR study).
37  tibiotalar ratio
(3 times)
Orthopedics
(3 times)
TTS (1 time)
2016 Talolisthesis in end stage ankle arthrosis.
38  time-to-repeat
(3 times)
Endocrinology
(2 times)
CBG (1 time)
ICU (1 time)
IMC (1 time)
2016 Is all hypoglycaemia treated as equal? An observational study of how the type of diabetes and treatment prescribed prior to admission influences quality of treatment of inpatient hypoglycaemia.
39  transcriptional termination region
(3 times)
Genetics
(1 time)
CGIs (1 time)
DME-like (1 time)
nc (1 time)
2008 Genetic heterogeneity of the dnaK gene locus including transcription terminator region (TTR) in Campylobacter lari.
40  transient thermoreflectance
(3 times)
Biomedical Engineering
(3 times)
FDTR (1 time)
2008 Pulse accumulation, radial heat conduction, and anisotropic thermal conductivity in pump-probe transient thermoreflectance.
41  Trauma Triage Rule
(3 times)
Emergency Medicine
(3 times)
--- 1992 Comparative performance of the Baxt Trauma Triage Rule.
42  true three-dimensional reconstruction
(3 times)
Diagnostic Imaging
(2 times)
ETTR (1 time)
TTCR (1 time)
1983 True Three-Dimensional Reconstruction (TTR) Application of Algorithm toward Full Utilization of Oblique Rays.
43  TH transport protein transthyretin
(2 times)
Toxicology
(1 time)
Cl-PFAESs (1 time)
PFASs (1 time)
PFOS (1 time)
2016 Binding interactions of perfluoroalkyl substances with thyroid hormone transport proteins and potential toxicological implications.
44  therapeutic range of INR
(2 times)
Vascular Diseases
(1 time)
ADI (1 time)
OAC (1 time)
SES (1 time)
2012 The influence of VKORC1 and CYP2C9 gene sequence variants on the stability of maintenance phase warfarin treatment.
45  Thyro-thymic thyroid rests
(2 times)
Medicine
(1 time)
PT (1 time)
TSH (1 time)
TT (1 time)
2015 Non-elevation of TSH after total thyroidectomy: a surgical surprise.
46  thyroglossal tract remnant
(2 times)
Otolaryngology
(1 time)
--- 2007 Thyroglossal duct cyst: personal experience and literature review.
47  thyroxin transport protein, transthyretin
(2 times)
Environmental Pollutants
(1 time)
--- 2006 Hydroxylated polychlorinated biphenyls (OH-PCBs): recent advances in wildlife contamination study.
48  tibiotarsal rotation
(2 times)
Veterinary Medicine
(2 times)
--- 1998 Factors on farms in eastern Australia associated with the development of tibiotarsal rotation in ostrich chicks.
49  time from initial diagnosis to relapse
(2 times)
Transplantation
(1 time)
ALC-R (1 time)
DLBCL (1 time)
IPI-R (1 time)
2008 Time of relapse after initial therapy significantly adds to the prognostic value of the IPI-R in patients with relapsed DLBCL undergoing autologous stem cell transplantation.
50  time to local recurrence
(2 times)
Neoplasms
(2 times)
OS (1 time)
TTLiR (1 time)
TTM (1 time)
2009 Adjuvant gemcitabine after surgical removal of aggressive malignant mammary tumours in dogs.
51  Time to reimplantation
(2 times)
Cardiology
(1 time)
ASA (1 time)
CIED (1 time)
PJIs (1 time)
2019 Re-implantation after extraction of a cardiac implantable electronic device.
52  time to reperfusion
(2 times)
Nervous System Diseases
(1 time)
MT (2 times)
AC (1 time)
AIS (1 time)
2019 Outcome, efficacy and safety of endovascular thrombectomy in ischaemic stroke according to time to reperfusion: data from a multicentre registry.
53  time to RT
(2 times)
Neoplasms
(1 time)
EC (1 time)
IC (1 time)
NPC (1 time)
2020 Impact of time to radiation therapy in adjuvant settings in endometrial carcinoma: A multicentric retrospective study.
54  time to tumor response
(2 times)
Neoplasms
(1 time)
PFS (2 times)
CK (1 time)
CR (1 time)
2013 Sunitinib objective response in metastatic renal cell carcinoma: analysis of 1059 patients treated on clinical trials.
55  total thermal response
(2 times)
Neurology
(2 times)
DA (2 times)
GFAP (2 times)
CP (1 time)
1998 Ontogeny of methamphetamine-induced neurotoxicity and associated hyperthermic response.
56  total tract retention
(2 times)
Veterinary Medicine
(2 times)
AID (2 times)
FI (2 times)
NC (2 times)
2021 Evaluation of the responses of broiler chickens to varying concentrations of phytate phosphorus and phytase. Ⅰ. Starter phase (day 1-11 post hatching).
57  transthoracic resistance
(2 times)
Cardiology
(2 times)
TMR (1 time)
VF (1 time)
1981 Transthoracic resistance in human defibrillation. Influence of body weight, chest size, serial shocks, paddle size and paddle contact pressure.
58  Transthyretin amyloid
(2 times)
Nephrology
(1 time)
AA (1 time)
FMF (1 time)
SAA (1 time)
2003 From renal amyloid deposits to the identification of the culprit genes.
59  transthyretin precursor
(2 times)
Biochemistry
(1 time)
6-PDGH (1 time)
AAT (1 time)
Apo J (1 time)
2008 Fine-needle aspiration of thyroid nodules: proteomic analysis to identify cancer biomarkers.
60  transthyretin protein
(2 times)
Computational Biology
(1 time)
FAP (2 times)
BEI (1 time)
CBS (1 time)
2011 Retrospective Mapping of SAR Data for TTR Protein in Chemico-Biological Space Using Ligand Efficiency Indices as a Guide to Drug Discovery Strategies.
61  transthyretin-bound
(2 times)
Chemistry Techniques, Analytical
(1 time)
RBP (2 times)
holo (1 time)
1990 Use of free and transthyretin-bound retinol-binding protein in serum as tests of vitamin A status in humans: effect of high creatinine concentrations in serum.
62  transverse transmission/reflection
(2 times)
Ophthalmology
(2 times)
ARROW (1 time)
MIM (1 time)
2009 Attenuation and mode profile determination of leaky/lossy modes in multilayer planar waveguides by a coupling simulation method.
63  treatment required
(2 times)
Gastroenterology
(1 time)
CS (1 time)
FL (1 time)
LTB (1 time)
2015 The role of "watch and wait" in intestinal follicular lymphoma in rituximab era.
64  triceps tendon ruptures
(2 times)
Orthopedics
(1 time)
DKS (1 time)
2015 Functional outcomes and complications after surgical repair of triceps tendon rupture.
65  Trien:tetraen ratio
(2 times)
Nutritional Sciences
(2 times)
IFALD (2 times)
PN (2 times)
AST (1 time)
2018 Children With Intestinal Failure Undergoing Intestinal Rehabilitation Are at Risk for Essential Fatty Acid Deficiency.
66  Tumour Tissue Repository
(2 times)
Preservation, Biological
(2 times)
BC (1 time)
GI (1 time)
PTC (1 time)
2014 Impact of a Permission to Contact (PTC) platform on biobank enrollment and efficiency.
67  turnover rate
(2 times)
Optometry
(1 time)
ADDE (1 time)
EDE (1 time)
ROC (1 time)
2009 Tear physiology of aqueous deficiency and evaporative dry eye.
68  fat-to-total fat ratio
(1 time)
Endocrine System Diseases
(1 time)
BMI (1 time)
LATR (1 time)
LM (1 time)
2016 Relationship of lean mass and obesity in Indian urban children and adolescents.
69  H2-treatment temperature
(1 time)
Biophysics
(1 time)
--- 2018 On the origin of high-temperature phenomena in Pt/Al2O3.
70  Met30-transthyretin
(1 time)
Genetics, Medical
(1 time)
FAP (1 time)
1998 A pedigree analysis with minimised ascertainment bias shows anticipation in Met30-transthyretin related familial amyloid polyneuropathy.
71  mRNA--transthyretin
(1 time)
Biology
(1 time)
AAT (1 time)
AFP (1 time)
ALB (1 time)
2006 In vitro differentiation of mouse ES cells into hepatocytes with coagulation factors VIII and IX expression profiles.
72  N-terminal region of transthyretin
(1 time)
Biochemistry
(1 time)
RBP (1 time)
THs (1 time)
2011 Effect of the N-terminal sequence on the binding affinity of transthyretin for human retinol-binding protein.
73  re-treatment
(1 time)
Hematology
(1 time)
CLL (1 time)
CR (1 time)
FC (1 time)
2010 Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome.
74  T-tube repair
(1 time)
Diagnostic Imaging
(1 time)
BDIs (1 time)
CJ (1 time)
ERC (1 time)
2008 Iatrogenic biliary injury: 13,305 cholecystectomies experienced by a single surgical team over more than 13 years.
75  T. trifolii resistance
(1 time)
Chemistry
(1 time)
AKR (1 time)
APR (1 time)
2020 Ethylene Is Not Essential for R-Gene Mediated Resistance but Negatively Regulates Moderate Resistance to Some Aphids in Medicago truncatula.
76  table-mounted autorefractometer/keratometer
(1 time)
CP (1 time)
HDY (1 time)
PO (1 time)
2022 Comparison of Adult Refractive Disorder Measurements Using HandyRef-K, Retinomax, Plusoptix, and Table-top Autorefractometer Devices.
77  table-top autorefractor
(1 time)
Eye Diseases
(1 time)
CV (1 time)
Rmax (1 time)
SEV (1 time)
2014 Comparison of the Retinomax hand-held autorefractor versus table-top autorefractor and retinoscopy.
78  tafamidis to ameliorate transthyretin
(1 time)
Biochemistry
(1 time)
--- 2015 Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy).
79  tafamidis treatment on transthyretin
(1 time)
Neurology
(1 time)
AEs (1 time)
mBMI (1 time)
NIS-LL (1 time)
2016 Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study.
80  tailored telescopic reconstruction
(1 time)
Gastroenterology
(1 time)
cDDRs (1 time)
DDR (1 time)
LDLT (1 time)
2010 Tailored telescopic reconstruction of the bile duct in living donor liver transplantation.
81  Talent Thoracic Retrospective Registry
(1 time)
Cardiology
(1 time)
--- 2008 Emergency treatment of the thoracic aorta: results in 113 consecutive acute patients (the Talent Thoracic Retrospective Registry).
82  tandem tetranucleotide repeat
(1 time)
Genetics
(1 time)
CF (1 time)
CFTR (1 time)
2002 [Analysis of the spectra of mutations and polymorphic loci of cystic fibrosis transmembrane conductance regulator in the population of Bashkortostan].
83  Tangtong Recipe
(1 time)
Complementary Therapies
(1 time)
VSMCs (1 time)
2009 [Effect of tangtong recipe on the proliferation of cultured iliac arterial smooth muscle cells of diabetic rats in vitro].
84  target INR
(1 time)
Pharmacology
(1 time)
AF (1 time)
GP (1 time)
INR (1 time)
2016 Impact of age on long-term anticoagulation and how gender and monitoring setting affect it: implications for decision making and patient management.
85  target INR range
(1 time)
Pharmacy
(1 time)
INR (1 time)
PEFS (1 time)
TER (1 time)
2019 Impact of a pharmacist-led education and follow-up service on anticoagulation control and safety outcomes at a tertiary hospital in China: a randomised controlled trial.
86  target international normalised ratio range
(1 time)
Medicine
(1 time)
AF (1 time)
VKAs (1 time)
VTE (1 time)
2014 Measures of vitamin K antagonist control reported in atrial fibrillation and venous thromboembolism studies: a systematic review.
87  target PRU ranges
(1 time)
General Surgery
(1 time)
SAC (1 time)
2021 Active management of the target P2Y12 reaction unit range in patients undergoing stent-assisted coil embolization for unruptured cerebral aneurysms.
88  target transthyretin gene
(1 time)
Drug Therapy
(1 time)
ATTR (1 time)
EMA (1 time)
FDA (1 time)
2019 Patisiran for the treatment of patients with familial amyloid polyneuropathy.
89  target tumour response
(1 time)
Radiology
(1 time)
GIST (1 time)
2005 Follow-up of gastro-intestinal stromal tumours (GIST) during treatment with imatinib mesylate by abdominal MRI.
90  targeted therapy resistance
(1 time)
Neoplasms
(1 time)
CSCs (1 time)
TT (1 time)
2016 At the crossroads of cancer stem cells and targeted therapy resistance.
91  tarsal tunnel release
(1 time)
General Surgery
(1 time)
PNR (1 time)
SFI (1 time)
SSEP (1 time)
2007 Effect of early nerve release on the progression of neuropathy in diabetic rats.
92  taurultame-taurinamide ratio
(1 time)
Pharmacology
(1 time)
HPLC (1 time)
2007 Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients.
93  taxa-time relationship
(1 time)
Medicine
(1 time)
CCA (1 time)
DO (1 time)
2014 Bacterial community dynamics and taxa-time relationships within two activated sludge bioreactors.
94  TBPA then was renamed transthyretin
(1 time)
Chemistry, Clinical
(1 time)
RBP (1 time)
TBPA (1 time)
2003 Transthyretin from discovery to now.
95  tectoridin
(1 time)
Drug Therapy
(1 time)
JSRVs (1 time)
RyR (1 time)
2000 Tectoridins modulate skeletal and cardiac muscle sarcoplasmic reticulum calcium-release channels.
96  Tectorigenin
(1 time)
Complementary Therapies
(1 time)
MRSA (1 time)
PGN (1 time)
TEM (1 time)
2014 The Antibacterial Assay of Tectorigenin with Detergents or ATPase Inhibitors against Methicillin-Resistant Staphylococcus aureus.
97  telehealth technology-related
(1 time)
Medical Informatics
(1 time)
OSMT (1 time)
2021 An Ostomy Self-management Telehealth Intervention for Cancer Survivors: Technology-Related Findings From a Randomized Controlled Trial.
98  temperature rise
(1 time)
Anthropology
(1 time)
BD (1 time)
CIVD (1 time)
JP (1 time)
2016 Cold-induced vasodilation comparison between Bangladeshi and Japanese natives.
99  temperature transition range
(1 time)
Dentistry
(1 time)
--- 1979 55 Nitinol wire: force developed as a function of "elastic memory".
100  tendon ruptures
(1 time)
Orthopedics
(1 time)
QTR (1 time)
2018 Simultaneous Ipsilateral Quadriceps and Triceps Tendon Rupture in a Patient with End-Stage Renal Failure.